Recruiting Substance Use Disorder Studies in Newark
Guanfacine for Alcohol Use Disorder (AUD)
The investigators assess whether guanfacine extended release (GXR; 3mg/d) compared with placebo (PBO) will attenuate drinking and drinking-related factors in N=200 men and women with Alcohol Use Disor...
High Dose Buprenorphine (BUP) Induction in the Emergency Department (ED)
This project, involving two distinct clinical trials, tests whether induction to a higher than currently recommended buprenorphine (BUP) induction dose is safe and can improve the proportion of patien...
About Substance Use Disorder Clinical Trials in Newark
Substance use disorder is a condition where the use of substances leads to health issues, disability, and failure to meet responsibilities. It encompasses alcohol, opioid, stimulant, and other drug addictions. Treatment includes behavioral therapy, medication-assisted treatment, and support programs.
There are currently 2 substance use disorder clinical trials recruiting participants in Newark, DELAWARE. These studies are seeking a combined 340 participants. Research is being sponsored by Indiana University, Rutgers, The State University of New Jersey. Clinical trial participation is free and participants receive study-related medical care at no cost.
Substance Use Disorder Clinical Trials in Newark — FAQ
Are there substance use disorder clinical trials in Newark?
Yes, there are 2 substance use disorder clinical trials currently recruiting in Newark, DELAWARE. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Newark?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Newark research site will contact you about next steps.
Are clinical trials in Newark free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Newark studies also compensate for your time and travel.
What substance use disorder treatments are being tested?
The 2 active trials in Newark are testing new therapies including novel drugs, biologics, and treatment approaches for substance use disorder.
Data updated March 2, 2026 from ClinicalTrials.gov